Coherus Oncology (CHRS) Change in Inventory (2018 - 2026)

Coherus Oncology has disclosed Change in Inventory across 9 years of filings, most recently posting $11.3 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at $11.3 million, down 49.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.2 million (down 85.55% YoY), and the FY2025 annual result was $17.1 million, down 46.46% from the prior year.
• Change in Inventory came in at $11.3 million for Q1 2026 at Coherus Oncology, up from $1.1 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $23.4 million in Q3 2022 to a low of -$3.8 million in Q2 2025.
• The 5-year median for Change in Inventory is $9.8 million (2022), against an average of $9.1 million.
• Across the five-year window, Change in Inventory soared 443.63% in 2022 and tumbled 153.08% in 2025, its largest moves.
• Coherus Oncology's Change in Inventory stood at $9.8 million in 2022, then grew by 20.44% to $11.8 million in 2023, then plunged by 45.28% to $6.5 million in 2024, then tumbled by 82.74% to $1.1 million in 2025, then jumped by 915.44% to $11.3 million in 2026.
• The last three Change in Inventory figures came in at $11.3 million (Q1 2026), $1.1 million (Q4 2025), and -$2.5 million (Q3 2025), per Business Quant data.